FGFR1 and neoplasm: The genomic landscape of FN-RMS is more heterogeneous, with a number of potential genetic drivers being implicated in their pathogenesis, including alterations in tumor suppressor genes (BCOR, NF1, and TP53), RAS activating mutations or FGFR1 amplifications5,6.